These findings also confirm the chronicity of obesity and suggest ongoing treatment is required to maintain improvements in weight and health." A new European consortium known as Sophia (Stratification of Obese Phenotypes to Optimize Future Obesity Therapy), led by scientists at University College Dublin, is now attempting to investigate this in more detail
A similar share cite the drugs side effects (13%), while fewer say they stopped because their condition improved (5%)
Additional eligibility criteria that Honest Care takes into account include: Prior Authorization (PA) is a process run by insurance plans to determine how necessary a medication is
Recent advancements in sustained-release formulations, like PLGA nanoparticles for delivering exendin-4, show promise in preclinical models but still require validation in human studies (Wang et al., 2023)
How Common Is Vomiting on GLP-1 Treatment
Krause GC, Lima KG, Dias HB, da Silva EFG, Haute GV, Basso BS, et al